Listen "#38, Dr. Mary Rozenman & Dr. Chris Probert, insitro"
Episode Synopsis
Dr. Mary Rozenman, Chief Financial Officer and Chief Business Officer at insitro, and Dr. Chris Probert, senior machine learning scientist at insitro discuss how insitro’s discovery process can start on either the clinical or cellular side, why scale is so important in every aspect of insitro’s model, and why diversity of experience and background can be a powerful tool in solving hard problems.
More episodes of the podcast AWS Health Innovation Podcast
#25, Kyle Kiser, Arrive Health
10/10/2022
#50, Exploring the Impact of Movement on Disease: Insights from Dr. Phil Wagner of Sparta Science
25/05/2023
#16 Craig Limoli, Wellsheet
18/04/2022
#40, Alon Joffe, Eleos
23/01/2023
#35, Emilio Galán, Robin
12/12/2022